Romatoid Artritte Nötrofil/ Lenfosit ve Platelet/ Lenfosit Oranlarının
Değerlendirilmesi
Amaç: Bu çalışmanın amacı, romatoid artrit (RA), hastalık aktivitesi ile hematolojik parametrelerden nötrofil-lenfosit oranı (NLO), platelet lenfosit oranı (PLO) ve eritrosit dağılım genişliği (RDW) arasındaki ilişkiyi incelemektir. Yöntemler: Yetmiş yedi romatoid artrit hastası ve 97 sağlıklı bireyden oluşmuş kontrol grubu bu retrospektif çalışmaya dâhil edildi. Kontrol grubuna sistemik ve kronik herhangi bir hastalığı olan kişiler dâhil edilmedi. Hastaların hastalık aktivite skorları (DAS 28) ve her iki grubun hematolojik parametreleri ve inflamasyon parametreleri istatistiksel olarak Student-t testi ve Spearman korelasyon testiyle karşılaştırıldı. Bulgular: Yaş ve cinsiyet açısından gruplar arasında fark yoktu. C-reaktif protein (CRP) ve eritrosit sedimentasyon hızı (ESH) seviyeleri RA hasta grubunda anlamlı olarak yüksekti (p<0,001). RA hasta grubunda hemoglobin ve ortalama platelet hacmi (MPV) düzeyleri anlamlı olarak düşük bulunurken (sırasıyla; p<0,001, p=0,022) , trombosit, RDW, NLO ve PLO ise anlamlı olarak yüksek bulundu (sırasıyla; p<0.001, p<0.001, p<0,001, p<0,001). Hasta grubunda farklı hastalık aktivitesi seviyelerinde (DAS 28) ESH (p<0,001), mutlak nötrofil (p=0,04), trombosit (p=0,019) seviyeleri anlamlı olarak yüksekken, lenfosit (%) (p=0.042) seviyeleri anlamlı olarak düşüktü. PLO düzeyleri ile MPV düzeyleri (r=-0,386) negatif anlamlı korelasyon gösterirken, RDW seviyeleri (r=0,354) ve NLO düzeyleri (r=0,618) ile anlamlı pozitif korelasyon göstermekteydi. Sonuç: Romatoid artrit hastalık aktivitesinin değerlendirilmesinde NLO ve PLO doğru sonuçlar verirken, klinik pratikte kullanışlı bir parametre olabilirler. Geniş katılımlı çalışmalarla bu parametreler ile hastalık şiddetinin belirlenmesinde daha özgül endeksler geliştirilebilir.
Evaluation of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Rheumatoid Arthritis
Objective: The purpose of this study is to investigate the relationship of disease activity with Neutrophil-Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) and red blood cell distribution width (RDW). Methods: Seventy seven RA patients and 97 healthy subjects were examined retrospectively. People with chronic and systemic diseases were excluded from control group of the study. The disease activity scores (DAS 28) of patient group, hematologic parameters and inflammation parameters of both groups were analyzed statistically using independent t-test and spearman correlation test. Results: Age and gender was not found different between groups. CRP and ESR levels were significantly higher in RA group (p<0.001). Hemoglobin and platelet count were lower (p<0.001 and p=0.022), while RDW, NLR, PLR and MPV levels were significantly higher in RA group (p<0.001, p<0.001. p<0.001, p<0.001, respectively). In patient group, ESR (p<0.001), lymphocytes (%) (p= 0.042), absolute neutrophil (p=0.047), and platelets (p= 0.019) were positively, whereas lymphocytes were negatively affected by improvement disease activity (DAS 28) scores. PLR levels significantly negatively correlated with MPV levels (r= -0.386) but showed a significant positive correlation with RDW (r= 0.354) and NLR levels (r= 0.618). Conclusion: NLR and PLR are important and promising factors for disease activity estimation of rheumatoid arthritis and may be used in clinical practice. In our opinion, larger studies consisting larger group will help determination of disease activity of RA by more specific indices using these parameters.
___
- 1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet
2010; 376: 1094-1108.
- 2. Choy EH, Panayi GS. Cytokine pathways and joint inflammation
in rheumatoid arthritis. N Engl J Med 2001;344:907-
916.
- 3. Karimifar M, Salesi M, Farajzadegan Z. The association of
anti-CCP1 antibodies with disease activity score 28 (DAS28)
in rheumatoid arthritis. Adv Biomed Res 2012;1:30.
- 4. Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity
and acute phase reactant levels are discordant among
patients with active rheumatoid arthritis: acute phase reactant
levels contribute separately to predicting outcome at
one year. Arthritis Res Ther 2014;16:R40.
- 5. Bowman SJ. Hematological manifestations of rheumatoid
arthritis. Scand J Rheumatol 2002;31:251-259.
- 6. van Riel PL. The development of the disease activity score
(DAS) and the disease activity score using 28 joint counts
(DAS28). Clin Exp Rheumatol 2014;32:65-74.
- 7. Lippi G, Targher G, Montagnana M, et al. Relation between
red blood cell distribution width and inflammatory biomarkers
in a large cohort of unselected outpatients. Arch
Pathol Lab Med 2009;133:628-632.
- 8. Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the
pre-treatment neutrophil-lymphocyte ratio as a prognostic
factor in a large European cohort of renal cell carcinoma
patients. Br J Cancer 2013;108:901-907.
- 9. Tamhane UU, Aneja S, Montgomery D, et al. Association
between admission neutrophil to lymphocyte ratio and outcomes
in patients with acute coronary syndrome. Am J Cardiol
2008;102:653-657.
- 10. de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia
and neutrophil-lymphocyte count ratio predict
bacteremia better than conventional infection markers in an
emergency care unit. Crit Care 2010;14:192.
- 11. Templeton AJ, Ace O, McNamara MG, et al. Prognostic role
of platelet to lymphocyte ratio in solid tumors: a systematic
review and meta-analysis. Cancer Epidemiol Biomarkers
Prev 2014;23:1204-1212.
- 12. Bath PM, Butterworth RJ. Platelet size: measurement,
physiology and vascular disease. Blood Coagul Fibrinolysis
1996;7:157-161.
- 13. Briggs C. Quality counts: new parameters in blood cell
counting. Int J Lab Hematol 2009;31:277-297.
- 14. Colglazier CL, Sutej PG. Laboratory testing in the rheumatic
diseases: a practical review. South Med J 2005;98:185-
191.
- 15. Gabay C, Kushner I. Acute-phase proteins and other systemic
responses to inflammation. N Engl J Med 1999;340:448-
454.
- 16. Kapci M, Turkdogan KA, Duman A, et.al. Biomarkers in
the diagnosis of acute appendicitis. JCEI 2014;5:250-255.
- 17. Mantovani A, Cassatella MA, Costantini C, et.al. Neutrophils
in the activation and regulation of innate and adaptive
immunity. Nat Rev Immunol 2011;11:519-531.
- 18. McDonald B, Pittman K, Menezes GB, et al. Intravascular
danger signals guide neutrophils to sites of sterile inflammation.
Science 2010;330:362-366.
- 19. Boilard E, Blanco P, Nigrovic PA. Platelets: active players
in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol
2012;8:534-542.
- 20. Celikbilek M, Dogan S, Ozbakir O, et al. Neutrophil-lymphocyte
ratio as a predictor of disease severity in ulcerative
colitis. J Clin Lab Anal 2013;27:72-76.
- 21. Ozturk ZA, Kuyumcu ME, Yesil Y, et al. Is there a link
between neutrophil-lymphocyte ratio and microvascular
complications in geriatric diabetic patients? J Endocrinol
Invest 2013;36:593-599.
- 22. Günbatar H, Ekin S, Sünnetçioğlu A, et.al. The relationship
between neutrophil-to-lymphocyte ratio and plateletto-lymphocyte
ratio in patients with obstructive sleep apnea
syndrome. Dicle Med J 2015;42:289-293.
- 23. Hu ZD, Sun Y, Guo J, et al. Red blood cell distribution
width and neutrophil/lymphocyte ratio are positively correlated
with disease activity in primary Sjogren’s syndrome.
CLB 2014;47:287-290.
- 24. Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio
(NLR), platelet to lymphocyte ratio (PLR) were useful
markers in assessment of inflammatory response and disease
activity in SLE patients. Mod Rheumatol 2015:1; 5-8.
- 25. Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte
ratio (PLR) is superior to neutrophil lymphocyte ratio
(NLR) as a predictive factor in patients with esophageal
squamous cell carcinoma. World J Surg Oncol 2014; 12:
58.
- 26. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify
inflammation in arthritis via collagen-dependent microparticle
production. Science 2010; 327: 580-583.
- 27. Uslu AU, Kucuk A, Sahin A, et al. Two new inflammatory
markers associated with Disease Activity Score-28
in patients with rheumatoid arthritis: neutrophil-lymphocyte
ratio and platelet-lymphocyte ratio. Int J Rheum Dis
2015;18:731-735.
- 28. Bath P, Algert C, Chapman N, et.al. Association of mean
platelet volume with risk of stroke among 3134 individuals
with history of cerebrovascular disease. Stroke
2004;35:622-626.
- 29. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean
platelet volume: a useful marker of inflammatory bowel
disease activity. Am J Gastroenterol 2001;96:776-781.
- 30. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet
volume (MPV) as an inflammatory marker in ankylosing
spondylitis and rheumatoid arthritis. Joint Bone Spine
2008;75:291-294.
- 31. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, et
al. Mean platelet volume in patients with rheumatoid arthritis:
the effect of anti-TNF-alpha therapy. Rheumatol Int
2010;30:1125-1129.
- 32. Yazici S, Yazici M, Erer B, et al. The platelet indices in
patients with rheumatoid arthritis: mean platelet volume reflects
disease activity. Platelets 2010;21:122-125.
- 33. Evans TC, Jehle D. The red blood cell distribution width. J
Emerg Med 1991;9:71-74.
- 34. Farkas N, Szabo A, Lorand V, et al. Clinical usefulness
of measuring red blood cell distribution width in patients
with systemic sclerosis. Rheumatology (Oxford) 2014; 53:
1439-1445.
- 35. Hu ZD, Chen Y, Zhang L, et al. Red blood cell distribution
width is a potential index to assess the disease activity of
systemic lupus erythematosus. Clin Chim Acta 2013; 425:
202-205.
- 36. Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red
blood cell distribution width predicts long-term outcome
regardless of anaemia status in acute heart failure patients.
Eur J Heart Fail 2009;11:840-846.
- 37. Hassan S, Antonelli M, Ballou S. Red cell distribution
width: a measure of cardiovascular risk in rheumatoid arthritis
patients? Clin Rheumatol 2015;34:1053-1057.
- 38. Rodriguez-Carrio J, Alperi-Lopez M, Lopez P, et al. Red
cell distribution width is associated with cardiovascular risk
and disease parameters in rheumatoid arthritis. Rheumatology
(Oxford) 2015;54:641-646.